CDH1 and neoplasm: The H&E staining and 11 IHC markers (Ki67, P63, GATA3, KRT5/6, KRT20, E-cadherin, 34βE12, PD-L1, EGFR, Nectin4, and HER2) were used to evaluate tumor phenotype maintenance.